Avacincaptad Pegol, A Novel C5 Inhibitor, Significantly Reduces the Mean Rate of Geographic Atrophy Growth in a Pivotal Clinical Trial
- Resource Type
- Journal
- Source
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE ; JUN 2020, 61 7, 3p.- Subject
- Language
- English
- ISSN
- 15525783